Bruker CorporationBRKRNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 2,418 | 2,531 | 2,965 |
| Gross Profit | 1,210 | 1,306 | 1,513 |
| Operating Income | 413 | 433 | 437 |
| Net Income | 277 | 297 | 427 |
| EBITDA | 497 | 519 | 676 |
| EPS Diluted | 1.81 | 1.99 | 2.90 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 1,068 | 646 | 488 |
| Total Current Assets | 2,472 | 2,113 | 2,164 |
| Total Assets | 3,650 | 3,612 | 4,250 |
| Total Current Liabilities | 939 | 914 | 1,202 |
| Total Liabilities | 2,565 | 2,480 | 2,837 |
| Total Equity | 1,071 | 1,114 | 1,377 |
| Total Debt | 1,394 | 1,270 | 1,380 |
| Net Debt | 326 | 625 | 891 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | 282 | 274 | 350 |
| Capital Expenditure | -92 | -129 | -107 |
| Free Cash Flow | 190 | 145 | 243 |
| Stock-Based Comp | 17 | 28 | 24 |
| Net Change in Cash | 386 | -423 | -157 |